CLINICAL_TRIALS
trial_result
· 2023-02-17
Clinical Trial Update: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda [Phase 2]
Summary
Phase 2 trial evaluating hydroxychloroquine with phlebotomy for porphyria cutanea tarda has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Porphyria Cutanea Tarda | Phase 2 | Status: COMPLETED | Results posted: 2023-02-17